AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...
The Medicare Advantage Open Enrollment Period (Jan 1–Mar 31) lets you switch plans or adjust coverage. Review your options to ...
Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment ...
Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...
The Biden administration’s justification of the first cycle of Medicare drug price negotiations is fueling curiosity and ...
On the other hand, Medicare Advantage plans have a more nuanced process. These plans require prior approval for all claims, making the insurance carrier the first point of contact for denials. While ...
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...
Social Security and Medicare are slowly running out of money, but what does that mean for the retirees counting on them?
According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to ...